Cash flow Neurizon Therapeutics Limited

Equities

NUZ

AU0000357261

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 11:40:02 15/05/2026 am IST			5-day change	1st Jan Change
0.0720 ^AUD	+4.35%		-5.26%	-15.29%

13/05	Neurizon Therapeutics receives ethics approval for Phase 1 Nuz-001 oral liquid formulation study	RE
13/05	Neurizon Therapeutics Gets Ethics Committee Nod for Neurodegenerative Disease Phase 1 Study; Shares Gain 3%	MT

d579a9f1d09001d39cf75969f8d5.u-AmKUpGRtHDe4oQ9QZqZX1lJgYwm3hmG9ik-NgIMBo.z7ZgYg4XGaHwLthYnFVeUToLSVEI2U8-U6DjgrZYZkPuiGccDjUcmoQW5Q

Published financial data: NEURIZON THERAPEUTICS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	21.4L	33.81L	28.24L	-	-
Other Revenues, Total	15.17L	11.29L	10L	8L	15.38L
Total Revenues	36.57L	45.1L	38.19L	8L	15.38L
Cost of Goods Sold, Total	2L	3L	13.36L	-	-
Gross Profit	34.32L	41.96L	24.83L	8L	15.38L
Selling General & Admin Expenses, Total	38.52L	47.42L	43.01L	24.41L	62.8L
Provision for Bad Debts	-	-	77.98T	-	-
Stock-Based Compensation (IS)	-	-	-	4L	5L
R&D Expenses	6L	8L	10.32L	38.47L	1.17Cr
Depreciation & Amortization - (IS)	3L	3L	3L	1.64T	44
Other Operating Expenses, Total	47.05L	58.16L	57.37L	66.59L	1.85Cr
Operating Income	-12.73L	-16.2L	-32.54L	-58.17L	-1.69Cr
Interest Expense, Total	-78.99T	-88.51T	-81.86T	-	-
Interest And Investment Income	14.72T	536	81.02T	24.47T	3L
Net Interest Expenses	-64.27T	-87.98T	-837	24.47T	3L
EBT, Excl. Unusual Items	-13.37L	-17.08L	-32.55L	-57.92L	-1.66Cr
Asset Writedown	-	-	-29.57L	-31.07L	-
EBT, Incl. Unusual Items	-13.37L	-17.08L	-62.12L	-89L	-1.66Cr
Earnings From Continuing Operations	-13.37L	-17.08L	-62.12L	-89L	-1.66Cr
Earnings Of Discontinued Operations	-	-	-	12.27L	-
Net Income to Company	-13.37L	-17.08L	-62.12L	-76.73L	-1.66Cr
Net Income - (IS)	-13.37L	-17.08L	-62.12L	-76.73L	-1.66Cr
Net Income to Common Incl Extra Items	-13.37L	-17.08L	-62.12L	-76.73L	-1.66Cr
Net Income to Common Excl. Extra Items	-13.37L	-17.08L	-62.12L	-89L	-1.66Cr
Per Share Items
Net EPS - Basic	-0	-0.01	-0.02	-0.02	-0.03
Basic EPS - Continuing Operations	-0	-0.01	-0.02	-0.02	-0.03
Basic Weighted Average Shares Outstanding	32Cr	32Cr	32Cr	37Cr	49Cr
Net EPS - Diluted	-0	-0.01	-0.02	-0.02	-0.03
Diluted EPS - Continuing Operations	-0	-0.01	-0.02	-0.02	-0.03
Diluted Weighted Average Shares Outstanding	32Cr	32Cr	32Cr	37Cr	49Cr
Normalized Basic EPS	-0	-0	-0.01	-0.01	-0.02
Normalized Diluted EPS	-0	-0	-0.01	-0.01	-0.02
Supplemental Items
EBITDA	-11.09L	-14.53L	-30.81L	-58.15L	-1.69Cr
EBITA	-12.73L	-16.2L	-32.54L	-58.17L	-1.69Cr
EBIT	-12.73L	-16.2L	-32.54L	-58.17L	-1.69Cr
Total Revenues (As Reported)	36.72L	45.11L	39L	-	-
Normalized Net Income	-8L	-10.68L	-20.34L	-36.2L	-1.04Cr
Supplemental Operating Expense Items
General and Administrative Expenses	14.64L	17.67L	16.61L	16.97L	45.75L
Research And Development Expense From Footnotes	6L	8L	10.32L	38.47L	1.17Cr
Stock-Based Comp., SG&A Exp. (Total)	2L	-46.34T	-10T	-	-
Stock-Based Comp., Other (Total)	-	-	-	4L	5L
Total Stock-Based Compensation	2L	-46.34T	-10T	4L	5L

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	30.2L	24.16L	27.06L	97.14L	41.61L
Short Term Investments	4.22T	4.22T	15.78T	10.16L	20T
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	30.24L	24.2L	27.22L	1.07Cr	41.81L
Accounts Receivable, Total	2L	2L	1L	18.49T	-
Other Receivables	-	-	-	-	-
Total Receivables	2L	2L	1L	18.49T	-
Inventory	10.08L	10.43L	0	-	-
Prepaid Expenses	62.54T	63.67T	85.69T	2L	97.49T
Other Current Assets, Total	19.58T	18.99T	65.59T	1L	78.66T
Total Current Assets	43.57L	37.31L	30.21L	1.11Cr	43.57L
Gross Property Plant And Equipment	50.61L	51.15L	22.12L	-	-
Accumulated Depreciation	-16.06L	-18.77L	-22.11L	-	-
Net Property Plant And Equipment	34.55L	32.38L	1.64T	-	1.5T
Other Intangibles, Total	31.42L	31.1L	31.07L	-	-
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	1.1Cr	1.01Cr	61.3L	1.11Cr	43.59L
Liabilities
Accounts Payable, Total	6L	6L	9L	8L	-
Accrued Expenses, Total	2L	2L	3L	34.08T	2L
Short-term Borrowings	-	2L	-	-	-
Current Portion of Long-Term Debt	38.21T	-	-	-	-
Current Portion of Leases	1L	1L	2L	-	-
Other Current Liabilities	-	-	-	35T	13.24L
Total Current Liabilities	9L	11.66L	13.47L	9L	15.33L
Long-Term Debt	-	-	-	-	-
Long-Term Leases	11.31L	10.37L	9L	-	-
Pension & Other Post Retirement Benefits	30.38T	31.02T	3.34T	649	4.97T
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	20.73L	22.34L	22.41L	9L	15.38L
Common Stock, Total	5.53Cr	5.53Cr	5.76Cr	6.99Cr	7.88Cr
Retained Earnings	-4.85Cr	-5.02Cr	-5.65Cr	-6.41Cr	-7.8Cr
Comprehensive Income and Other	20.93L	27.48L	27.15L	44.25L	19.98L
Total Common Equity	88.8L	78.44L	38.89L	1.02Cr	28.21L
Total Equity	88.8L	78.44L	38.89L	1.02Cr	28.21L
Total Liabilities And Equity	1.1Cr	1.01Cr	61.3L	1.11Cr	43.59L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	32Cr	32Cr	35Cr	49Cr	49Cr
ECS Total Common Shares Outstanding	32Cr	32Cr	35Cr	45Cr	49Cr
Book Value / Share	0.03	0.02	0.01	0.02	0.01
Tangible Book Value	57.38L	47.35L	8L	1.02Cr	28.21L
Tangible Book Value Per Share	0.02	0.01	0	0.02	0.01
Total Debt	12.78L	13.85L	10.49L	0	0
Net Debt	-17.46L	-10.35L	-16.73L	-1.07Cr	-41.81L
Account Code - Inventory Valuation	5	5	5	-	3
Inventories - Raw Materials, Total	10.57T	10.57T	4.36T	-	-
Inventories - Work In Process, Total	52.88T	59.04T	-	-	-
Inventories - Finished Goods, Total	9L	10L	10.51L	-	-
Machinery, Total	36.35L	36.34L	16.54L	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	77.98T	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	-13.37L	-17.08L	-62.12L	-76.73L	-1.66Cr
Depreciation & Amortization - CF	3L	3L	3L	1.64T	44
Depreciation & Amortization, Total	3L	3L	3L	1.64T	44
(Gain) Loss From Sale Of Asset	-	-	180	-12.27L	-
Asset Writedown & Restructuring Costs	-	32.52T	35.83L	31.07L	-
Stock-Based Compensation (CF)	2L	-46.34T	-10T	4L	5L
Other Operating Activities, Total	45.89T	-	5L	-	-
Change In Accounts Receivable	55.73T	56.63T	-40.9T	1L	16.99T
Change In Inventories	-2L	-34.92T	-4.22T	-	-
Change In Accounts Payable	2.01T	44.63T	3L	5L	5L
Change in Other Net Operating Assets	-7.06T	8.5T	-36.68T	-4L	12.82L
Cash from Operations	-9L	-13.32L	-15.64L	-51.69L	-1.43Cr
Capital Expenditure	-1L	-43.38T	-34.76T	-	-1.54T
Divestitures	-	-	-	-2L	-
Sale (Purchase) of Intangible assets	-36.32T	-	-167	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-10L	-20T
Cash from Investing	-1L	-43.38T	-34.93T	-11.65L	-21.54T
Long-Term Debt Issued, Total	-	2L	-	-	-
Total Debt Issued	-	2L	-	-	-
Long-Term Debt Repaid, Total	-3L	-2L	-4L	-	-
Total Debt Repaid	-3L	-2L	-4L	-	-
Issuance of Common Stock	15.82L	7L	24L	1.29Cr	87.96L
Other Financing Activities, Total	-44.99T	-	-2L	4L	-35T
Cash from Financing	12.16L	8L	18.89L	1.33Cr	87.61L
Net Change in Cash	1L	-6L	3L	70.08L	-55.53L
Supplemental Items
Cash Interest Paid	33.1T	88.51T	81.86T	-	-
Levered Free Cash Flow	-6L	-8L	-4L	-36.53L	-92.14L
Unlevered Free Cash Flow	-6L	-7L	-4L	-36.53L	-92.14L
Change In Net Working Capital	85.76T	-74.19T	-13.83L	4L	-9L
Net Debt Issued / Repaid	-3L	52.49T	-4L	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	-7.33	-9.63	-25.09	-42.14	-136.74
Return on Total Capital	-7.89	-10.45	-28.71	-47.94	-162.25
Return On Equity %	-15.37	-20.43	-105.88	-126.08	-254.33
Return on Common Equity	-15.37	-20.43	-105.88	-126.08	-254.33
Margin Analysis
Gross Profit Margin %	93.84	93.03	65.02	100	100
SG&A Margin	105.34	105.15	112.61	290	408.37
EBITDA Margin %	-30.33	-32.22	-80.68	-690.89	-1.1T
EBITA Margin %	-34.81	-35.92	-85.19	-691.08	-1.1T
EBIT Margin %	-34.81	-35.92	-85.19	-691.08	-1.1T
Income From Continuing Operations Margin %	-36.57	-37.87	-162.64	-1.06T	-1.08T
Net Income Margin %	-36.57	-37.87	-162.64	-911.61	-1.08T
Net Avail. For Common Margin %	-36.57	-37.87	-162.64	-1.06T	-1.08T
Normalized Net Income Margin	-22.86	-23.67	-53.26	-430.11	-674.39
Levered Free Cash Flow Margin	-16.83	-17.04	-11.01	-434.01	-599.16
Unlevered Free Cash Flow Margin	-15.48	-15.81	-9.67	-434.01	-599.16
Asset Turnover
Asset Turnover	0.34	0.43	0.47	0.1	0.2
Fixed Assets Turnover	1.04	1.35	2.36	-	-
Receivables Turnover (Average Receivables)	7.93	15.83	16.93	-	-
Inventory Turnover (Average Inventory)	0.24	0.31	2.56	-	-
Short Term Liquidity
Current Ratio	4.78	3.2	2.24	12.42	2.84
Quick Ratio	3.58	2.23	2.13	12	2.73
Operating Cash Flow to Current Liabilities	-1.03	-1.14	-1.16	-5.77	-9.32
Days Sales Outstanding (Average Receivables)	46.01	23.06	21.56	-	-
Days Outstanding Inventory (Average Inventory)	1.51T	1.19T	142.47	-	-
Average Days Payable Outstanding	541.94	607.51	-	-	-
Cash Conversion Cycle (Average Days)	1.02T	606.34	-	-	-
Long Term Solvency
Total Debt/Equity	14.39	17.66	26.97	-	-
Total Debt / Total Capital	12.58	15.01	21.24	-	-
LT Debt/Equity	12.74	13.22	22.9	-	-
Long-Term Debt / Total Capital	11.14	11.24	18.03	-	-
Total Liabilities / Total Assets	18.93	22.16	36.56	8.06	35.29
EBIT / Interest Expense	-16.12	-18.31	-39.75	-	-
EBITDA / Interest Expense	-12.34	-14.75	-35.76	-	-
(EBITDA - Capex) / Interest Expense	-13.63	-15.24	-36.18	-	-
Total Debt / EBITDA	-1.31	-1.06	-0.36	-	-
Net Debt / EBITDA	1.79	0.79	0.57	1.85	0.25
Total Debt / (EBITDA - Capex)	-1.19	-1.03	-0.35	-	-
Net Debt / (EBITDA - Capex)	1.62	0.77	0.56	1.85	0.25
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.24	23.33	-15.32	-3.66	82.7
Gross Profit, 1 Yr. Growth %	-11.42	22.27	-40.82	-3.66	82.7
EBITDA, 1 Yr. Growth %	1.35	31.02	112.04	340.04	191.26
EBITA, 1 Yr. Growth %	2.11	27.27	100.82	252.95	191.18
EBIT, 1 Yr. Growth %	2.11	27.27	100.82	252.95	191.18
Earnings From Cont. Operations, 1 Yr. Growth %	-1.81	27.73	263.63	466.09	86.45
Net Income, 1 Yr. Growth %	-1.81	27.73	263.63	23.53	116.26
Normalized Net Income, 1 Yr. Growth %	-1.81	27.73	90.53	268.44	186.47
Diluted EPS Before Extra, 1 Yr. Growth %	-7.93	27.27	259	389.92	41.85
Accounts Receivable, 1 Yr. Growth %	-18.72	-23.4	-20.01	-87.52	-
Inventory, 1 Yr. Growth %	17.55	3.46	-100	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-3.19	-6.28	-99.95	-	-
Total Assets, 1 Yr. Growth %	1.93	-7.99	-39.17	81.47	-60.82
Tangible Book Value, 1 Yr. Growth %	5.9	-17.49	-83.49	1.21T	-72.42
Common Equity, 1 Yr. Growth %	4.15	-11.67	-50.42	163	-72.42
Cash From Operations, 1 Yr. Growth %	-26.14	42.04	17.41	230.43	176.53
Capital Expenditures, 1 Yr. Growth %	236.49	-57.35	-19.86	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-31.3	24.86	-45.28	-676.04	152.22
Unlevered Free Cash Flow, 1 Yr. Growth %	-31.12	25.98	-48.21	-676.04	152.22
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-8.28	4.63	2.2	-56.8	32.67
Gross Profit, 2 Yr. CAGR %	-7.53	4.07	-14.93	-55.21	32.67
EBITDA, 2 Yr. CAGR %	-9.32	15.23	66.68	100.05	258
EBITA, 2 Yr. CAGR %	-8.52	14	59.87	89.48	220.58
EBIT, 2 Yr. CAGR %	-8.52	14	59.87	89.48	220.58
Earnings From Cont. Operations, 2 Yr. CAGR %	-7.15	11.99	115.52	128.26	224.88
Net Income, 2 Yr. CAGR %	-7.15	11.99	115.52	111.94	63.44
Normalized Net Income, 2 Yr. CAGR %	-7.15	11.99	56	84.15	224.88
Diluted EPS Before Extra, 2 Yr. CAGR %	-22.62	8.25	113.75	111.02	163.62
Accounts Receivable, 2 Yr. CAGR %	-3.32	-21.1	-21.73	-68.41	-
Inventory, 2 Yr. CAGR %	28.36	10.28	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	18.31	-4.75	-97.82	-	-4.36
Total Assets, 2 Yr. CAGR %	12.89	-3.16	-25.19	5.06	-15.68
Tangible Book Value, 2 Yr. CAGR %	14.88	-6.52	-63.09	46.98	89.96
Common Equity, 2 Yr. CAGR %	9.14	-4.08	-33.82	14.19	-14.84
Cash From Operations, 2 Yr. CAGR %	-22.31	2.42	29.14	96.97	202.28
Capital Expenditures, 2 Yr. CAGR %	-16.74	19.79	-41.54	-	-78.92
Levered Free Cash Flow, 2 Yr. CAGR %	-26.62	-7.39	-17.34	118.02	281.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	-28.68	-6.85	-19.23	126.31	281.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.91	1.24	-2.5	-38.72	-30.14
Gross Profit, 3 Yr. CAGR %	4.94	1.5	-13.78	-37.4	-28.44
EBITDA, 3 Yr. CAGR %	-22.81	2.52	41.21	73.72	126.73
EBITA, 3 Yr. CAGR %	-20.46	2.12	37.68	65.94	118.66
EBIT, 3 Yr. CAGR %	-20.46	2.12	37.68	65.94	118.66
Earnings From Cont. Operations, 3 Yr. CAGR %	-19.06	3.27	65.83	88.1	113.37
Net Income, 3 Yr. CAGR %	-19.06	3.27	65.83	79.03	113.37
Normalized Net Income, 3 Yr. CAGR %	-19.06	3.27	33.69	63.01	113.37
Diluted EPS Before Extra, 3 Yr. CAGR %	-37.33	-8.66	61.43	78.29	84.85
Accounts Receivable, 3 Yr. CAGR %	-0.87	-10.54	-20.74	-57.56	-
Inventory, 3 Yr. CAGR %	20.65	19.46	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	11.47	9.47	-92.29	-	-92.26
Total Assets, 3 Yr. CAGR %	9.43	5.45	-17.06	0.52	-24.38
Tangible Book Value, 3 Yr. CAGR %	12.5	2.88	-47.56	21.25	-15.86
Common Equity, 3 Yr. CAGR %	7.55	1.71	-23.02	4.82	-28.89
Cash From Operations, 3 Yr. CAGR %	-15.43	-5	7.19	76.63	120.55
Capital Expenditures, 3 Yr. CAGR %	-51.08	-33.38	4.77	-	-67.1
Levered Free Cash Flow, 3 Yr. CAGR %	-25.32	-12.39	-22.29	81.05	128.87
Unlevered Free Cash Flow, 3 Yr. CAGR %	-27.08	-13.79	-23.4	86.17	134.64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.11	6.4	3.22	-27.99	-17.89
Gross Profit, 5 Yr. CAGR %	6.68	7.18	-3.51	-26.83	-16.87
EBITDA, 5 Yr. CAGR %	-8.65	4.13	5.02	33.94	72.96
EBITA, 5 Yr. CAGR %	-7.23	4.34	5.16	30.77	68.51
EBIT, 5 Yr. CAGR %	-7.23	4.34	5.16	30.77	68.51
Earnings From Cont. Operations, 5 Yr. CAGR %	-19.38	4.92	19.76	41.82	64.87
Net Income, 5 Yr. CAGR %	-19.38	4.92	19.76	37.68	64.87
Normalized Net Income, 5 Yr. CAGR %	-6.34	4.92	5.24	30.15	64.87
Diluted EPS Before Extra, 5 Yr. CAGR %	-36.94	-12.95	2.38	27.68	49.23
Accounts Receivable, 5 Yr. CAGR %	20.81	-3.56	-9.81	-41.01	-
Inventory, 5 Yr. CAGR %	25.65	16.46	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	13.68	13.18	-76.91	-	-78.88
Total Assets, 5 Yr. CAGR %	11.85	4.22	-6.01	5.29	-16.51
Tangible Book Value, 5 Yr. CAGR %	24.53	4.46	-27.97	18.66	-12.24
Common Equity, 5 Yr. CAGR %	12.07	2.55	-11.44	6.53	-19.85
Cash From Operations, 5 Yr. CAGR %	-10.13	1.19	0.17	27.17	62.28
Capital Expenditures, 5 Yr. CAGR %	-41.62	-5.32	-47.47	-	-44.83
Levered Free Cash Flow, 5 Yr. CAGR %	-25.31	-1.6	-22.23	26.16	59.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	-26.41	-2.17	-24.04	26.83	62.15